Charles River Laboratories International (CRL) EBT Margin (2009 - 2025)

Charles River Laboratories International (CRL) has reported EBT Margin for 17 consecutive years, with 29.58% the latest figure, recorded in Q4 2025.

• In Q4 2025, EBT Margin fell 796.0% year-over-year to 29.58%; the TTM figure through Dec 2025 stood at 2.48% (down 478.0% YoY), while the FY2025 annual figure was 2.48%, down 478.0% from the prior year.
• EBT Margin came in at 29.58% for Q4 2025 at Charles River Laboratories International, down from 8.68% in the prior quarter.
• The five-year high for EBT Margin was 22.27% in Q4 2022, with the low at 29.58% in Q4 2025.
• Average EBT Margin over 5 years is 8.52%, with a median of 11.89% recorded in 2022.
• Across the five-year window, EBT Margin jumped 419 bps in 2022 and tumbled 4222 bps in 2024, its largest moves.
• Year by year, EBT Margin stood at 18.08% in 2021, then grew by 23 bps to 22.27% in 2022, then decreased by 8 bps to 20.59% in 2023, then slumped by 205 bps to 21.62% in 2024, then slumped by 37 bps to 29.58% in 2025.
• According to Business Quant data, EBT Margin over the past three periods registered 29.58%, 8.68%, and 6.92% for Q4 2025, Q3 2025, and Q2 2025 respectively.